| Margaret Elizabeth Kitsos, LICSW | |
|
1 South Prospect St, Fahc Dept Of Psychiatry, Burlington, VT 05401 | |
| (802) 847-1407 | |
| Not Available |
| Full Name | Margaret Elizabeth Kitsos |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 38 Years |
| Location | 1 South Prospect St, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073706446 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 0890000200 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Three major Ohio universities and four hospitals have joined with the March of Dimes Foundation to establish a new collaborative research program aimed exclusively at finding the unknown causes of premature birth.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage, or nephrotoxicity.
In early January 2021, travelers returning to Tokyo, Japan, from Amazonas, Brazil, were screened for COVID-19 at the airport. A few days later, the National Institute of Infectious Disease of Japan announced that the travelers had returned with a new variant of the SARS-CoV-2 virus.
Over the past 18 months, researchers have learned much about COVID-19 and its viral cause, SARS-CoV-2. They know how the virus enters the body, coming in through the nose and mouth and beginning its infection in the mucus layers of the nasal passageway.
Nabi Biopharmaceuticals announced today that it has successfully completed the technology transfer of program know-how associated with the sale of the PentaStaphTM vaccine candidate to GlaxoSmithKline Biologicals S.A.. As a result of successfully completing this milestone, Nabi is eligible to receive $8 million under the agreement governing Nabi's sale of PentaStaphTM (Pentavalent S. aureus Vaccine) and related assets to GSK.
› Verified 9 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Three major Ohio universities and four hospitals have joined with the March of Dimes Foundation to establish a new collaborative research program aimed exclusively at finding the unknown causes of premature birth.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage, or nephrotoxicity.
In early January 2021, travelers returning to Tokyo, Japan, from Amazonas, Brazil, were screened for COVID-19 at the airport. A few days later, the National Institute of Infectious Disease of Japan announced that the travelers had returned with a new variant of the SARS-CoV-2 virus.
Over the past 18 months, researchers have learned much about COVID-19 and its viral cause, SARS-CoV-2. They know how the virus enters the body, coming in through the nose and mouth and beginning its infection in the mucus layers of the nasal passageway.
Nabi Biopharmaceuticals announced today that it has successfully completed the technology transfer of program know-how associated with the sale of the PentaStaphTM vaccine candidate to GlaxoSmithKline Biologicals S.A.. As a result of successfully completing this milestone, Nabi is eligible to receive $8 million under the agreement governing Nabi's sale of PentaStaphTM (Pentavalent S. aureus Vaccine) and related assets to GSK.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret Elizabeth Kitsos, LICSW 1 South Prospect St, Fahc Dept Of Psychiatry, Burlington, VT 05401 Ph: (802) 847-1407 | Margaret Elizabeth Kitsos, LICSW 1 South Prospect St, Fahc Dept Of Psychiatry, Burlington, VT 05401 Ph: (802) 847-1407 |
News Archive
Three major Ohio universities and four hospitals have joined with the March of Dimes Foundation to establish a new collaborative research program aimed exclusively at finding the unknown causes of premature birth.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage, or nephrotoxicity.
In early January 2021, travelers returning to Tokyo, Japan, from Amazonas, Brazil, were screened for COVID-19 at the airport. A few days later, the National Institute of Infectious Disease of Japan announced that the travelers had returned with a new variant of the SARS-CoV-2 virus.
Over the past 18 months, researchers have learned much about COVID-19 and its viral cause, SARS-CoV-2. They know how the virus enters the body, coming in through the nose and mouth and beginning its infection in the mucus layers of the nasal passageway.
Nabi Biopharmaceuticals announced today that it has successfully completed the technology transfer of program know-how associated with the sale of the PentaStaphTM vaccine candidate to GlaxoSmithKline Biologicals S.A.. As a result of successfully completing this milestone, Nabi is eligible to receive $8 million under the agreement governing Nabi's sale of PentaStaphTM (Pentavalent S. aureus Vaccine) and related assets to GSK.
› Verified 9 days ago
Shannon Kadish, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1138 Pine St, Burlington, VT 05401 Phone: 802-488-6600 | |
Elyza Moore, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1138 Pine St, Burlington, VT 05401 Phone: 802-488-6000 Fax: 802-488-6919 | |
Ellyn Leamon, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1138 Pine St, Burlington, VT 05401 Phone: 802-863-1326 | |
Lauren Carpenter, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 | |
Elaine Soto, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 300 Flynn Ave, Burlington, VT 05401 Phone: 802-488-6300 | |
Jenifer D'aiello, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-5331 Fax: 802-847-7765 | |
Kathleen Browne, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 Fax: 802-860-4324 |